- Report
- October 2024
- 187 Pages
Global
From €3238EUR$3,545USD£2,769GBP
€3598EUR$3,939USD£3,076GBP
- Report
- April 2025
- 200 Pages
Global
From €4101EUR$4,490USD£3,507GBP
- Report
- June 2023
- 180 Pages
Global
From €5434EUR$5,950USD£4,647GBP
- Report
- June 2023
- 112 Pages
Global
From €4110EUR$4,500USD£3,515GBP
- Report
- February 2024
- 110 Pages
Global
From €4338EUR$4,750USD£3,710GBP
- Report
- December 2023
- 148 Pages
Global
From €4064EUR$4,450USD£3,476GBP
- Report
- January 2025
- 132 Pages
Global
From €868EUR$950USD£742GBP
Cell banking outsourcing is a service used in drug discovery to provide access to a variety of cell lines for use in research. It is a cost-effective way to obtain cell lines for use in drug development, as it eliminates the need to maintain and store cell lines in-house. Cell banking outsourcing also provides access to a wide range of cell lines, including those that are difficult to obtain or maintain in-house. This allows researchers to quickly access the cell lines they need for their research. Additionally, cell banking outsourcing can provide access to specialized cell lines, such as those used in stem cell research.
Cell banking outsourcing is a growing market, with many companies offering services to researchers. These companies provide a range of services, including cell line acquisition, storage, and maintenance. They also offer services such as cell line authentication, cryopreservation, and cell line banking. Companies in this market include ATCC, Coriell Institute for Medical Research, and CellBank Australia. Show Less Read more